S. Ben-Horin

Genetics · 2009–2014

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom S. Ben-Horin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Stefan Schreiber
  2. S. Hanauer
  3. P. Rutgeerts
  4. W. Sandborn
  5. J. Colombel

Papers from S. Ben-Horin's perspective

Ordered by how strongly the researchers S. Ben-Horin trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. (Clinical Gastroenterology and Hepatology)
  2. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. (Gastroenterology)
  3. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. (Gastroenterology)
  4. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. (Gastroenterology)
  5. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. (Gastroenterology)
  6. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee (American Journal of Gastroenterology)
  7. Placebo Effects: Biological, Clinical and Ethical Advances (The Lancet)
  8. Inflammatory bowel disease: clinical aspects and established and evolving therapies (The Lancet)
  9. A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene (Science)
  10. The immunological and genetic basis of inflammatory bowel disease (Nature reviews. Immunology)

Their papers